Related Experiment Videos
Causes and consequences of hyperhomocyst(e)inemia
1Department of Pathophysiology, University of Bonn, Germany.
Summary
Hyperhomocysteinemia, elevated homocysteine levels, increases vascular disease risk. Treatment involves cofactor supplementation for genetic causes and vitamin correction for non-genetic factors.
Area of Science:
- Biochemistry
- Genetics
- Vascular Medicine
Background:
- Hyperhomocysteinemia is defined by elevated plasma homocysteine levels.
- Classifications include moderate, intermediate, and severe forms, with Kang's system widely adopted.
- Causes are categorized as genetic or non-genetic.
Purpose of the Study:
- To review the etiology and classification of hyperhomocysteinemia.
- To discuss treatment strategies based on the cause and severity.
- To highlight the association between hyperhomocysteinemia and vascular disease risk.
Main Methods:
- Literature review of hyperhomocysteinemia definitions, causes, and treatments.
- Analysis of classification systems for disease severity.
- Discussion of therapeutic approaches for genetic and non-genetic etiologies.
Main Results:
- Severe hyperhomocysteinemia presents with homocystinuria and early-onset symptoms, requiring mandatory treatment.
- Even moderate hyperhomocysteinemia significantly elevates vascular disease risk.
- Treatment efficacy depends on addressing the underlying cause, whether genetic or non-genetic.
Conclusions:
- Effective management of hyperhomocysteinemia is crucial for preventing severe health consequences and vascular complications.
- Genetic defects are treated by enhancing enzyme activity via cofactor supplementation.
- Non-genetic forms often resolve with correction of vitamin deficiencies, with nutritional doses potentially sufficient for milder cases and prevention.